TrialClinical breast cancer2014

Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer.

Ewa Mrózek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.